Patent application number | Description | Published |
20100090667 | OUTPUT COMPENSATED VOLTAGE REGULATOR, AN IC INCLUDING THE SAME AND A METHOD OF PROVIDING A REGULATED VOLTAGE - A voltage regulator, a method of regulating voltage and an IC including a voltage regulator. In one embodiment, the voltage regulator includes: (1) a DC precision amplifier configured to generate a DC precision signal based on a reference voltage and a regulated output of the voltage regulator and (2) a response amplifier, coupled in parallel with the DC precision amplifier, configured to generate an error signal based on the reference voltage and the regulated output, the response amplifier further configured to generate the regulated output based on a regulating signal comprised of the error signal and the DC precision signal. The DC precision amplifier may be a CMOS amplifier and the response amplifier may be a NPN amplifier. | 04-15-2010 |
20100238575 | WRITE DRIVER MONITORING AND DETECTION - Electronic circuitry and methods are disclosed for monitoring a portion of a write driver, for example, a steady state value of a write driver of a hard disk drive preamplifier. Based on a result of the monitoring, a condition, such as a fault, can be detected in the write driver. For example, apparatus for monitoring a write driver of a disk drive system comprises a comparator circuit coupled to an output of the write driver and configured to compare a value present at the output of the write driver with a reference value such that at least one condition associated with the write driver is detectable as a result of the comparison of the write driver output value and the reference value. | 09-23-2010 |
Patent application number | Description | Published |
20100111873 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 05-06-2010 |
20130345414 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 12-26-2013 |
Patent application number | Description | Published |
20120045590 | APPARATUS AND METHOD FOR PLASMA TREATMENT OF CONTAINERS - An apparatus ( | 02-23-2012 |
20120097159 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF - A composition for modifying a surface of a substrate, the composition comprising: (a) a first polyfluoropolyether silane of the Formula Ia: CF | 04-26-2012 |
20120103330 | MEDICINAL INHALATION DEVICE - A medical inhalation device or a component thereof having a diamond-like glass coating comprising hydrogen and on a hydrogen free basis about 20 to about 40 atomic percent of silicon, greater than 39 atomic percent of carbon, and less than 33 down to and including zero atomic percent of oxygen. | 05-03-2012 |
20130229378 | OPTICAL DEVICE SURFACE TREATMENT PROCESS AND SMUDGE-RESISTANT ARTICLE PRODUCED THEREBY - A surface treatment process comprises (a) providing at least one optical device; (b) providing a curable surface treatment composition comprising (1) at least one fluorinated organosilane compound comprising (i) a monovalent segment selected from polyfluoroalkyl, polyfluoroether, polyfluoropolyether, and combinations thereof and (ii) a monovalent endgroup comprising at least one silyl moiety comprising at least one group selected from hydrolyzable groups, hydroxyl, and combinations thereof, and (2) at least one fluorinated organosilane compound comprising (i) a multivalent segment selected from polyfluoroalkane, polyfluoroether, polyfluoropolyether, and combinations thereof and (ii) at least two monovalent endgroups, each independently comprising at least one silyl moiety comprising at least one group selected from hydrolyzable groups, hydroxyl, and combinations thereof; (c) applying the curable surface treatment composition to the optical device; and (d) curing the applied, curable surface treatment composition. | 09-05-2013 |
Patent application number | Description | Published |
20090088815 | PROACTIVE INTERACTIVE LIMITS OVERRIDE FOR IMPLANTABLE MEDICAL DEVICE USER INTERFACE - This document discusses, among other things, an external device that includes a communication circuit, a programming interface including a display, and a processor. The processor includes a parameter analyzer to apply a rule to a combination of operating parameter values of the IMD to determine operating parameter interaction. The display includes a first warning that is displayed when the parameter analyzer determines that a combination of operating parameter values entered via the programming interface is not allowed, and a second warning that is displayed when the parameter analyzer determines that a combination of operating parameters values entered via the programming interface is allowable but not recommended. The processor is configured to program the operating parameter values associated with the second warning into the IMD only after a user acknowledgement of the second warning is received from a user via the programming interface. | 04-02-2009 |
20090156909 | System For Contextual Display of Data From an Implantable Medical Device - Embodiments of the invention are related to data management systems, amongst other things. In an embodiment, the invention includes a video output and a processor in communication with the video output, wherein the video output and the processor are configured to display information regarding a patient in a first format and a second format through the video output simultaneously, the first format comprising a graphical formal and the second format comprising a textual format, the information displayed in the first format divided into a plurality of phases, wherein the system is configured to automatically change the information displayed in the second format based on user selection of one of the plurality of phases. Other embodiments are also included herein. | 06-18-2009 |
20090157144 | Phased Deactivation of Functionality in Implantable Medical Device Systems - Embodiments of the invention are related to systems for interfacing with implantable medical devices, amongst other things. In an embodiment, the invention includes an external medical system including a processor and a telemetry circuit in communication with the processor, the processor configured to communicate with an implanted medical device. The system can be configured to query a system user after a first period of time in which indicators of system use are not detected. The system can be further configured to deactivate one or more data transmission features of the implanted medical device after a second period of time in which one or more indicators of system use are not detected. Other embodiments are also included herein. | 06-18-2009 |
20090171412 | HANDLING IMPROPER DEVICE DATA IN IMPLANTABLE DEVICES - A system and method for handling data received from an implantable medical device (IMD) is provided. The method includes communicating a device parameter value of an IMD device parameter from the IMD to an external device and determining, at the external device, that the communicated device parameter value is at an improper value. Additionally, in response to the determining that the communicated device parameter value is at an improper value, automatically performing at least one of re-programming the IMD device parameter with a selected substitute device parameter value, ignoring, or purging non-programmable data. | 07-02-2009 |
20090171414 | INTERROGATION OF STORED DATA IN IMPLANTABLE DEVICES - A system and method is provided for receiving user input to perform an initial interrogation of an implantable medical device (IMD) using an external device. The initial interrogation commences a communication session between the IMD and the external device. During the initial interrogation, first data is transferred from the IMD to the external device and displayed at the external device. The first data comprises device configuration data of the IMD. During the initial interrogation, background transfer of second data from the IMD to the external device is initiated during or after the display of first data, without requiring a user request for the second data. The second data comprises historical physiological episode data. | 07-02-2009 |
20100036448 | SYSTEMS AND METHODS FOR CONTROLLING RATE RESPONSIVE PACING - Embodiments of the invention are related to medical systems and methods that can be used to control features of implanted medical devices, amongst other things. In an embodiment, the invention includes a medical system including an external medical device. The external medical device including a video output and a processor in communication with the video output. The system can be configured to display information through the video output as a graph, the graph comprising data representing pacing rates of an implantable device as a function of activity level over time. The system can further be configured to accept user input through direct manipulation of the graph. Other embodiments are also included herein. | 02-11-2010 |
20120116471 | DYNAMIC BATTERY MANAGEMENT IN AN IMPLANTABLE DEVICE - One aspect of this disclosure relates to a system for dynamic battery management in implantable medical devices. An embodiment of the system includes two or more devices for measuring battery capacity for an implantable medical device battery. The embodiment also includes a controller connected to the measuring devices. The controller is adapted to combine the measurements from the measuring devices using a weighted average to determine battery capacity consumed. According to various embodiments, at least one of the measuring devices includes a coulometer. At least one of the measuring devices includes a capacity-by-voltage device, according to an embodiment. The system further includes a display in communication with the controller in various embodiments. The display is adapted to provide a depiction of battery longevity in units of time remaining in the life of the implantable medical device battery, according to various embodiments. Other aspects and embodiments are provided herein. | 05-10-2012 |
20120185017 | PHASED DEACTIVATION OF FUNCTIONALITY IN IMPLANTABLE MEDICAL DEVICE SYSTEMS - Embodiments of the invention are related to systems for interfacing with implantable medical devices, amongst other things. In an embodiment, the invention includes an external medical system including a processor and a telemetry circuit in communication with the processor, the processor configured to communicate with an implanted medical device. The system can be configured to query a system user after a first period of time in which indicators of system use are not detected. The system can be further configured to deactivate one or more data transmission features of the implanted medical device after a second period of time in which one or more indicators of system use are not detected. Other embodiments are also included herein. | 07-19-2012 |
20130150914 | HANDLING IMPROPER DEVICE DATA IN IMPLANTABLE DEVICES - A system and method for handling data received from an implantable medical device (IMD) is provided. The method includes communicating a device parameter value of an IMD device parameter from the IMD to an external device and determining, at the external device, that the communicated device parameter value is at an improper value. Additionally, in response to the determining that the communicated device parameter value is at an improper value, automatically performing at least one of re-programming the IMD device parameter with a selected substitute device parameter value, ignoring, or purging non-programmable data. | 06-13-2013 |
20130226263 | SYSTEMS AND METHODS OF GATHERING DATA AT THE TIME OF PARAMETER OVERRIDES - The current technology is relevant to a system having a programming device in communication with an implantable medical device, an implantable sensor, and electronic medical records. A user interface is in communication with the programming device, and the user interface is configured to receive an override parameter and override rationale. | 08-29-2013 |
20140005749 | METHOD AND APPARATUS FOR DETECTION OF LEAD REVERSAL | 01-02-2014 |
20140214107 | DYNAMIC BATTERY MANAGEMENT IN AN IMPLANTABLE DEVICE - One aspect of this disclosure relates to a system for dynamic battery management in implantable medical devices. An embodiment of the system includes two or more devices for measuring battery capacity for an implantable medical device battery. The embodiment also includes a controller connected to the measuring devices. The controller is adapted to combine the measurements from the measuring devices using a weighted average to determine battery capacity consumed. According to various embodiments, at least one of the measuring devices includes a coulometer. At least one of the measuring devices includes a capacity-by-voltage device, according to an embodiment. The system further includes a display in communication with the controller in various embodiments. The display is adapted to provide a depiction of battery longevity in units of time remaining in the life of the implantable medical device battery, according to various embodiments. Other aspects and embodiments are provided herein. | 07-31-2014 |
20140236261 | METHOD AND SYSTEM FOR INDICATING NEUROSTIMULATION DELIVERY - A method and system for providing an indication of delivery of a neural stimulation therapy is disclosed. In an example, a method may include identifying current timing of an intermittent neural stimulation (INS) programmed in an implantable medical device (IMD) where the programmed INS includes alternating stimulation ON and stimulation OFF times and a timing for delivering stimulation bursts of a plurality of stimulation pulses during the stimulation burst ON times. An indication of the current timing of the INS may be provided using an INS indicator of an external device. | 08-21-2014 |
Patent application number | Description | Published |
20110190851 | STIMULATION MODE SWITCHING BASED ON TISSUE IMPEDANCE STABILITY - Implantable medical devices switch from a constant current mode of operation to a constant voltage mode of operation. The switching may be based on the device determining that tissue impedance stability has occurred. The determination may be a measurement of output voltage stability of the constant current source or based on other factors such as an amount of time that has elapsed. The switching may be as the result of an externally generated request such as by a clinician via an external device. The implantable medical device may begin constant voltage mode by utilizing stimulation parameters based on those initially programmed for constant current mode and based upon a measurement of voltage amplitude being output by the constant current source prior to the switch. | 08-04-2011 |
20130193914 | ADAPTIVE RATE RECHARGING SYSTEM - Devices, systems, and techniques for selecting a period for charging an implantable rechargeable power source are disclosed. Implantable medical devices may include a rechargeable power source that can be transcutaneously charged. A system may control a charging module to begin charging the rechargeable power source of the implantable medical device with a high power level. The system may then determine an estimated heat loss based on power initially delivered to the rechargeable power source when beginning the charging. Based on this estimated heat loss during the initial period of recharging, the system may select a boost period that includes a duration of time that the rechargeable power source is charged with the high power level. | 08-01-2013 |
20130197613 | MANAGING RECHARGE POWER FOR IMPLANTABLE MEDICAL DEVICES - Devices, systems, and techniques for controlling charging power based on a cumulative thermal dose to a patient are disclosed. Implantable medical devices may include a rechargeable power source that can be transcutaneously charged. An external charging device may calculate an estimated cumulative thermal dose delivered to the patient during charging over a predetermined period of time. Based on the estimated cumulative thermal dose, the external charging device may select a power level for subsequent charging of the rechargeable power source. In one example, the charging device may select a high power level when the cumulative thermal dose has not exceeded a thermal dose threshold and select a low power level when the cumulative thermal dose has exceeded the thermal dose threshold. | 08-01-2013 |
20130211478 | OPERATIONAL ELECTRODE IMPEDANCE MEASUREMENT FOR AN IMPLANTABLE MEDICAL STIMULATOR - Controller, system and method for an implantable medical device having a plurality of electrodes, said implantable device being capable of delivering a therapeutic stimulation to a patient. An electrode interface is operatively coupled between a plurality of electrodes and a control module. The control module uses an electrode interface to obtain a plurality of measurements of impedance values for a plurality of selected pairs of individual ones of the plurality of electrodes. A user interface displays an indicia, indicative of operability of a group of at least one of said plurality of electrodes, based on a comparison of said plurality of measurements to a predetermined range, said indicia being a qualitative representation of operability of said group of at least one of said plurality of electrodes. | 08-15-2013 |
Patent application number | Description | Published |
20110022507 | MORTGAGE LOAN HAVING EXERCISABLE OPTION - Embodiments of the present invention relate to methods and apparatuses for providing, processing, and/or servicing a mortgage loan having one or more exercisable options. For example, in some embodiments, a method is provided that includes storing, in a non-transitory computer-readable medium, one or more terms of an exercisable option, where the option is incorporated into a mortgage loan, where the mortgage loan includes a fixed interest rate, and where the option includes an interest rate modification feature, such that exercising the option results in the value of the fixed interest rate being modified from a first value to a second value. | 01-27-2011 |
20110022512 | MODIFIABLE MORTGAGE - Embodiments of the present invention relate to methods and apparatuses for providing, processing, and/or servicing a mortgage loan having one or more exercisable options. For example, in some embodiments, a method is provided that includes storing, in a non-transitory computer-readable medium, one or more terms of an exercisable option, where the option is incorporated into a mortgage loan, where exercising the option results in one or more terms of the mortgage loan being modified, and where one or more terms of the option are based at least partially on a non-mortgage relationship between a borrower associated with the mortgage loan and a lender associated with the mortgage loan. | 01-27-2011 |
20110246345 | FLAT FEE MORTGAGE - Described herein are various apparatuses, methods, and computer program products for providing a mortgage environment that determines a flat fee for a mortgage that includes all lender and third-party fees associated with the mortgage. By providing a mortgage with a flat fee, the process of a borrower obtaining a mortgage from a lender can be easier because the borrower's worries about multiple fees, charges, and other costs can be combined into a single, flat fee. Some embodiments of the invention determine the flat fee based at least partially on analysis of various loan characteristics. | 10-06-2011 |
Patent application number | Description | Published |
20120222165 | VARIETY CORN LINE NPIQ4345 - The present invention provides an inbred corn line designated NPIQ4345, methods for producing a corn plant by crossing plants of the inbred line NPIQ4345 with plants of another corn plant. The invention further encompasses all parts of inbred corn line NPIQ4345, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line NPIQ4345, and plants produced according to these methods. | 08-30-2012 |
20130024989 | Variety Corn Line NPIC3821 - The present invention provides an inbred corn line designated NPIC3821, methods for producing a corn plant by crossing plants of the inbred line NPIC3821 with plants of another corn plant. The invention further encompasses all parts of inbred corn line NPIC3821, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line NPIC3821, and plants produced according to these methods. | 01-24-2013 |
20130024990 | Variety Corn Line NPID3216 - The present invention provides an inbred corn line designated NPID3216, methods for producing a corn plant by crossing plants of the inbred line NPID3216 with plants of another corn plant. The invention further encompasses all parts of inbred corn line NPID3216, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line NPID3216, and plants produced according to these methods. | 01-24-2013 |
20130024996 | Variety Corn Line NPID3013 - The present invention provides an inbred corn line designated NPID3013, methods for producing a corn plant by crossing plants of the inbred line NPID3013 with plants of another corn plant. The invention further encompasses all parts of inbred corn line NPID3013, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line NPID3013, and plants produced according to these methods. | 01-24-2013 |
20130024997 | Variety Corn Line NPID3719 - The present invention provides an inbred corn line designated NPID3719, methods for producing a corn plant by crossing plants of the inbred line NPID3719 with plants of another corn plant. The invention further encompasses all parts of inbred corn line NPID3719, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line NPID3719, and plants produced according to these methods. | 01-24-2013 |
20140068808 | Variety Corn Line ID3517 - The present invention provides an inbred corn line designated ID3517, methods for producing a corn plant by crossing plants of the inbred line ID3517 with plants of another corn plant. The invention further encompasses all parts of inbred corn line ID3517, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line ID3517, and plants produced according to these methods. | 03-06-2014 |
20150033399 | VARIETY CORN LINE HID3259 - The present invention provides an inbred corn line designated HID3259, methods for producing a corn plant by crossing plants of the inbred line HID3259 with plants of another corn plant. The invention further encompasses all parts of inbred corn line HID3259, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line HID3259, and plants produced according to these methods. | 01-29-2015 |
20150033403 | VARIETY CORN LINE HID3780 - The present invention provides an inbred corn line designated HID3780, methods for producing a corn plant by crossing plants of the inbred line HID3780 with plants of another corn plant. The invention further encompasses all parts of inbred corn line HID3780, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line HID3780, and plants produced according to these methods. | 01-29-2015 |
Patent application number | Description | Published |
20150245580 | VARIETY CORN LINE HID3464 - The present invention provides an inbred corn line designated HID3464, methods for producing a corn plant by crossing plants of the inbred line HID3464 with plants of another corn plant. The invention further encompasses all parts of inbred corn line HID3464, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line HID3464, and plants produced according to these methods. | 09-03-2015 |
20150245581 | VARIETY CORN LINE HID3634 - The present invention provides an inbred corn line designated HID3634, methods for producing a corn plant by crossing plants of the inbred line HID3634 with plants of another corn plant. The invention further encompasses all parts of inbred corn line HID3634, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line HID3634, and plants produced according to these methods. | 09-03-2015 |
20150245582 | VARIETY CORN LINE HID4488 - The present invention provides an inbred corn line designated HID4488, methods for producing a corn plant by crossing plants of the inbred line HID4488 with plants of another corn plant. The invention further encompasses all parts of inbred corn line HID4488, including culturable cells. Additionally provided herein are methods for introducing transgenes into inbred corn line HID4488, and plants produced according to these methods. | 09-03-2015 |